BackImpel Pharmaceuticals Overview

Impel Pharmaceuticals Net Income

Profitability analysis for IMPL.

Quarterly Net Income

-$13.81M
↑ 55.58% YoY

As of Sep 2023

Annual Net Income (TTM)

-$82.84M
↑ 23.3% YoY

Trailing 12 months ending Sep 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin